4.6 Article

A novel cyclic peptide (Naturido) modulates glia-neuron interactions in vitro and reverses ageing-related deficits in senescence-accelerated mice

期刊

PLOS ONE
卷 16, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0245235

关键词

-

资金

  1. Japan Society for the Promotion of Science
  2. DKS Co., Ltd. (the parent company of Biococoon Laboratories, Inc.)

向作者/读者索取更多资源

The study confirmed the significant effects of the novel cyclic peptide Naturido from medicinal fungus on both glia and neurons, promoting astrocyte proliferation, activating specific genes, and increasing dendrite length in neurons. Moreover, Naturido was found to shift microglial activation towards anti-inflammatory and neuroprotective phenotypes, leading to improved brain function and hair quality in senescence-accelerated mice. These results suggest that Naturido may be a promising modulator for the treatment of senescence, Alzheimer's disease, and other neurodegenerative diseases.
The use of agents that target both glia and neurons may represent a new strategy for the treatment of ageing disorders. Here, we confirmed the presence of the novel cyclic peptide Naturido that originates from a medicinal fungus (Isaria japonica) grown on domestic silkworm (Bombyx mon). We found that Naturido significantly enhanced astrocyte proliferation and activated the single copy gene encoding the neuropeptide VGFand the neuron-derived NGFgene. The addition of the peptide to the culture medium of primary hippocampal neurons increased dendrite length, dendrite number and axon length. Furthermore, the addition of the peptide to primary microglial cultures shifted CGA-activated microglia towards antiinflammatory and neuroprotective phenotypes. These findings of in vitro glia-neuron interactions led us to evaluate the effects of oral administration of the peptide on brain function and hair ageing in senescence-accelerated mice (SAMP8). In vivo analyses revealed that spatial learning ability and hair quality were improved in Naturido-treated mice compared with untreated mice, to the same level observed in the normal ageing control (SAMR1). These data suggest that Naturido may be a promising glia-neuron modulator for the treatment of not only senescence, but also Alzheimer's disease and other neurodegenerative diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据